BioNTech BNTX 深 沪
已收盘 05-08 16:00:00 美东时间
94.125
+1.105
+1.19%
华盛通- 最 高95.9899
- 今 开93.38
- 成交量 103.55万股
- 最 低 92.50
- 昨 收 93.02
- 总市值 238.03亿
- 52周最高 124.00
- 市盈率 静 --
- 换手率 0.41%
- 52周最低 79.52
- 委 比 -20.72%
- 总股本 2.53亿
- 历史最高 462.4502
- 量 比 0.89
- 振 幅 3.75%
- 历史最低 10.9752
- 每 手 1
- 风险率 7.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With Novavax Stock On Friday?
Moderna is researching hantavirus vaccine with U.S. Army while Novavax stock rises due to increased public health threat
05-09 02:18
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Philips Reports Strong Order Intake Despite Uncertain Macro Environment
Philips Q1 shows 6% order growth and EPS beat, while margins and technical signals point to mixed near-term momentum.
05-06 23:55
CureVac 创始人怒了！被 BioNTech 收购就关厂，德国药企上演 “收购绞杀”
（来源：DOLC） 德国生物医药行业再掀风暴。曾在新冠疫情期间与BioNTech并肩竞争mRNA疫苗的CureVac，如今在被收购后，却面临总部关闭和大规模裁员...
05-06 23:08
Wells Fargo Maintains Overweight on BioNTech, Lowers Price Target to $140
Wells Fargo analyst Mohit Bansal maintains BioNTech (NASDAQ:BNTX) with a Overweight and lowers the price target from $150 to $140.
05-06 21:28
PRESS DIGEST-Financial Times - May 6
PRESS DIGEST-Financial Times - May 6 May 6 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines Apple reaches $250 million settlement over delayed 'AI Siri' Meta plans advanced 'agentic' AI assis
05-06 09:43
BioNTech outlines up to $1B buyback and targets ~€500M annual savings while reaffirming 2026 revenue of €2.0B-€2.3B
Earnings Call Insights: BioNTech (BNTX) Q1 2026 Management view CEO Ugur Sahin said BioNTech’s 2026 priorities are to “accelerate the late-stage development of our oncology assets,” build “momentum in...
05-06 03:22
BioNTech eliminating more than 1800 jobs as COVID vaccine sales dwindle
BioNTech (BNTX) will lay off 1,860 employees in manufacturing positions and refocus its efforts on its oncology pipeline in the face of plummeting revenue from its COVID-19 vaccine. The German biotech...
05-06 01:17
BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape
BioNTech shares fall after Q1 revenue miss and wider net loss, despite lower-than-expected loss and long-term cost-saving plans.
05-06 00:18
